Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | United States | $17.41M | 64,464,412 | 19.61% | 80.39% | Net Buying | Net Buying |
| INTZ | INTRUSION INC | United States | $9.32M | 4,904,195 | 0.23% | 99.77% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.47M | 466,761,105 | 0.18% | 0.00% | ||
| PPBT | PURPLE BIOTECH LTD | Israel | $9.92M | 198,386,080 | 0.15% | 0.00% | ||
| YTEN | YIELD10 BIOSCIENCE INC | United States | $1.85M | 642,546 | 1.99% | 98.01% | Net Buying | |
| IQ | IQIYI INC | China | $4.96B | 6,716,137,085 | 3.18% | 0.00% | ||
| BPTH | BIO-PATH HOLDINGS INC | United States | $3.71M | 1,656,235 | 0.10% | 99.90% | ||
| CLNN | CLENE INC | United States | $49.19M | 128,433,721 | 4.09% | 52.66% | Net Buying | Net Selling |
| BIOL | BIOLASE INC | United States | $5.14M | 33,394,979 | 0.77% | 55.47% | ||
| BNED | BARNES & NOBLE EDUCATION INC | United States | $10.10M | 53,156,369 | 10.25% | 89.75% | Net Selling | |
| LIFE | ATYR PHARMA INC | United States | $132.16M | 69,010,940 | 38.06% | 22.13% | Net Buying | |
| LYRA | LYRA THERAPEUTICS INC | United States | $21.70M | 60,964,859 | 11.98% | 14.19% | Net Buying | |
| DARE | DARE BIOSCIENCE INC | United States | $36.39M | 101,092,900 | 6.16% | 25.30% | ||
| APLM | APOLLOMICS INC | United States | $30.70M | 89,495,790 | 0.74% | 0.00% | ||
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.25M | 16,309,393 | 4.99% | 65.32% | Net Buying | |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $60.07M | 36,850,279 | 6.10% | 7.77% | Net Selling | Net Selling |
| GOSS | GOSSAMER BIO INC | United States | $167.85M | 226,218,652 | 31.98% | 14.47% | Net Buying | Net Selling |
| OCUP | OCUPHIRE PHARMA INC | United States | $44.85M | 25,924,158 | 0.89% | 99.11% | Net Buying | Net Buying |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $47.74M | 27,918,560 | 6.08% | 38.25% | ||
| MVST | MICROVAST HOLDINGS INC | United States | $131.95M | 317,196,095 | 14.10% | 31.20% | Net Selling | |
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $150.48M | 208,127,550 | 28.32% | 13.96% | Net Selling | Net Buying |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.57M | 3,112,401 | 1.03% | 98.97% | Net Buying | |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $32.99M | 39,272,434 | 1.07% | 98.93% | Net Buying | Net Selling |
| LUMO | LUMOS PHARMA INC | United States | $18.18M | 8,116,488 | 11.54% | 88.46% | Net Buying | Net Buying |
| SYBX | SYNLOGIC INC | United States | $20.14M | 11,707,011 | 0.54% | 99.46% | Net Selling | Net Selling |
| GOEV | CANOO INC | United States | $181.70M | 68,567,495 | 4.36% | 95.64% | Net Buying | |
| FEMY | FEMASYS INC | United States | $29.55M | 22,220,718 | 5.82% | 8.01% | ||
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $92.14M | 53,260,467 | 16.07% | 24.11% | ||
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $11.92M | 50,924,284 | 3.06% | 34.31% | Net Selling | Net Buying |
| IMRX | IMMUNEERING CORP | United States | $46.56M | 29,653,355 | 14.14% | 46.80% | Net Selling | Net Selling |
| GNLX | GENELUX CORP | United States | $98.27M | 26,996,740 | 18.73% | 5.19% | Net Selling | Net Selling |
| PRST | PRESTO AUTOMATION INC | United States | $12.77M | 80,791,967 | 7.69% | 68.69% | Net Buying | |
| CARA | CARA THERAPEUTICS INC | United States | $41.55M | 54,675,954 | 26.49% | 53.39% | Net Selling | Net Selling |
| ACET | ADICET BIO INC | United States | $115.04M | 82,173,503 | 27.45% | 19.49% | Net Buying | |
| GEVO | GEVO INC | United States | $168.20M | 236,232,717 | 24.12% | 11.14% | Net Selling | |
| CVKD | CADRENAL THERAPEUTICS INC | United States | $7.09M | 16,008,469 | 1.56% | 46.72% | Net Buying | |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $73.06M | 54,933,774 | 42.82% | 21.62% | Net Buying | Net Buying |
| AMPX | AMPRIUS TECHNOLOGIES INC | United States | $124.70M | 94,472,655 | 4.33% | 75.78% | Net Selling | Net Buying |
| AQMS | AQUA METALS INC | United States | $45.40M | 113,226,006 | 15.97% | 15.25% | Net Selling | |
| NTBL | NOTABLE LABS LTD | Israel | $9.74M | 9,018,261 | 1.95% | 98.05% | Net Selling | |
| TPST | TEMPEST THERAPEUTICS INC | United States | $75.09M | 22,217,265 | 2.95% | 97.05% | ||
| INAB | IN8BIO INC | United States | $49.86M | 44,123,949 | 16.42% | 51.06% | Net Buying | |
| DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.78% | 0.00% | ||
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $173.90M | 23,405,637 | 1.30% | 98.70% | Net Buying | Net Buying |
| FBIO | FORTRESS BIOTECH INC | United States | $34.65M | 19,916,124 | 12.17% | 60.54% | Net Buying | Net Buying |
| VOR | VOR BIOPHARMA INC | United States | $118.77M | 68,259,602 | 24.85% | 10.15% | Net Selling | Net Selling |
| TARA | PROTARA THERAPEUTICS INC | United States | $76.39M | 20,589,976 | 3.21% | 96.79% | Net Selling | Net Selling |
| IKNA | IKENA ONCOLOGY INC | United States | $64.42M | 48,258,111 | 30.28% | 18.22% | ||
| MBRX | MOLECULIN BIOTECH INC | United States | $11.37M | 2,311,536 | 1.74% | 98.26% | Net Buying | |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $147.44M | 31,913,887 | 27.36% | 67.96% | Net Buying | Net Buying |
| SPRB | SPRUCE BIOSCIENCES INC | United States | $32.92M | 41,154,799 | 29.55% | 44.89% | Net Selling | Net Selling |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $566.19M | 68,380,857 | 14.07% | 50.20% | Net Selling | Net Selling |
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $12.40M | 284,379,960 | 0.03% | 5.95% | ||
| AGEN | AGENUS INC | United States | $226.37M | 20,999,261 | 46.57% | 53.43% | Net Buying | Net Buying |
| NOTV | INOTIV INC | United States | $58.18M | 25,971,450 | 14.42% | 43.41% | Net Buying | |
| PGEN | PRECIGEN INC | United States | $363.48M | 252,419,690 | 13.41% | 72.43% | Net Buying | Net Selling |
| SBEV | SPLASH BEVERAGE GROUP INC | United States | $13.68M | 47,656,088 | 5.58% | 2.91% | Net Buying | |
| IPA | IMMUNOPRECISE ANTIBODIES LTD | Canada | $30.21M | 26,315,260 | 6.04% | 0.00% | ||
| SGMO | SANGAMO THERAPEUTICS INC | United States | $120.36M | 207,510,076 | 33.26% | 15.51% | Net Selling | Net Selling |
| GRTS | GRITSTONE BIO INC | United States | $81.43M | 108,569,374 | 21.39% | 20.10% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.